Tempus AI Inc. misled investors about the worth of its deals and artificial intelligence abilities, obscuring weaknesses with its operations and revenue prospects, a proposed class action said.
Share prices fell more than 19% to close at $53.20 on May 28, the day a short-seller report accused Tempus of overhyping its AI-driven revenue and questioned top brass’ work histories, said the complaint filed Thursday in the US District for the Northern District of Illinois. It was the stock’s steepest single-day slide since the AI-enabled medical analytics company went public in June 2024, according to data compiled by Bloomberg.
Spruce Point ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.